NCT00337623View on ClinicalTrials.gov

Impact of Systemic Corticosteroid Therapy on Lens Transparency and Quantification of Lens Autofluorescence.

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2000

Study Completion Date

July 31, 2006

Conditions
Patients With Systemic Inflammatory Diseases Receiving for the First Time a Protracted General Corticostroid Therapy
Interventions
DRUG

Prednisolone

Trial Locations (1)

63003

Clermont-Ferrand University Hospital, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT00337623 - Impact of Systemic Corticosteroid Therapy on Lens Transparency and Quantification of Lens Autofluorescence. | Biotech Hunter | Biotech Hunter